15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
about
Crystal Structures of Three Classes of Non-Steroidal Anti-Inflammatory Drugs in Complex with Aldo-Keto Reductase 1C3Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ as an electrophilic mediator.Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.A Role for the PPARgamma in Cancer Therapy.PPARgamma and Apoptosis in Cancer.Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignanciesThe Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products.Roles of Eicosanoids in Prostate Cancer.Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells.Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines."Combination-oriented molecular-targeting prevention" of cancer: a model involving the combination of TRAIL and a DR5 inducer.Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells.Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by α- and β-secretases: relevance to Alzheimer's disease.
P2860
Q27671816-FCB5B636-C42D-46F9-AAED-DEA8D6D031D8Q33692555-E73413E7-64A8-4FED-BF46-0FF2EA8FC346Q33720126-8981B9DA-7188-45A3-B725-4214D886A266Q34477927-477F8B91-A839-4437-BD05-05E80978BA98Q34508284-ED4939DC-B4DD-4283-9376-8B3C272525FBQ34618859-99E940D1-F270-405B-ADFD-2D7BBE034107Q34933261-5E277107-A4B1-427D-B02F-08CEB4EA2992Q36691611-41B9DB83-B375-4C9B-B68B-78BC351D7F8FQ36742811-29472B75-5B0B-4C4B-8591-A43EF2515128Q37182794-6439601E-F474-44DD-B969-7D43AD9FC222Q37211832-B550ED9B-C911-4A51-9403-F3B993D371CEQ37592857-CC3B5A4A-35AD-46B8-9A99-E437F1C3C721Q38968834-1D79D5A4-8815-4C77-8B1B-CF39D635487CQ39650265-2F35AD8A-F0CC-4B45-80A5-AD74042E3CCEQ41119138-E6082B37-E5DE-468F-8567-72D50F42FCEDQ47129762-C6F14BAC-CB44-44AA-9C57-338A008B7388Q47391212-988E2CD7-C821-4797-804D-86305AB5BC95
P2860
15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
15-Deoxy-Delta12,14-prostaglan ...... iates TRAIL-induced apoptosis.
@en
type
label
15-Deoxy-Delta12,14-prostaglan ...... iates TRAIL-induced apoptosis.
@en
prefLabel
15-Deoxy-Delta12,14-prostaglan ...... iates TRAIL-induced apoptosis.
@en
P2093
P1476
15-Deoxy-Delta12,14-prostaglan ...... iates TRAIL-induced apoptosis.
@en
P2093
Junji Kouhara
Mano Horinaka
Miki Wakada
Susumu Nakata
Takumi Shiraishi
Tatsushi Yoshida
Toshiyuki Sakai
P304
P356
10.1158/1535-7163.MCT-06-0023
P577
2006-07-01T00:00:00Z